TTC9C-BSCL2 Fusion FISH Probe
The TTC9C-BSCL2 Fusion FISH Probe is used to confirm a fusion of the TTC9C and BSCL2 genes. The fusion of the TTC9C and BSCL2 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TTC9C-BSCL2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TTC9C-BSCL2-20-AQAQ | 20 (40 μL) | 200 μL |
|
BSCL2 Gene Summary
This gene encodes the multi-pass transmembrane protein protein seipin. This protein localizes to the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2).[provided by RefSeq, Mar 2011]
Gene Name: BSCL2, Seipin Lipid Droplet Biogenesis Associated
Chromosome: CHR11: 62457733 -62477091
Locus: 11q12.3
TTC9C Gene Summary
The Tetratricopeptide Repeat Domain 9C (TTC9C) gene is located on chr11 :62495951-62506108 at 11q12.3.
Gene Name: Tetratricopeptide Repeat Domain 9C
Chromosome: CHR11: 62495951 -62506108
Locus: 11q12.3
Gene Diseases
The TTC9C BSCL2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|